Unknown

Dataset Information

0

Insights on β-blockers for the treatment of hypertension: A survey of health care practitioners.


ABSTRACT: A quantitative survey was completed by 103 primary care physicians (PCPs) and 59 cardiologists who regularly prescribed β-blockers to assess knowledge and use of this heterogeneous drug class for hypertension. More cardiologists than PCPs chose β-blockers as initial antihypertensive therapy (30% vs 17%, P < 0.01). Metoprolol and carvedilol were the most commonly prescribed β-blockers. Cardiologists rated "impact on energy" and "arterial vasodilation" as more important than PCPs (P < 0.05/<0.01, respectively). Awareness of vasodilation was greater for carvedilol (52%) than nebivolol (31%). Association between β-blockers and clinical variables included nebivolol with β1 -selectivity, nebivolol and carvedilol with vasodilation and efficacy in older patients and African Americans, metoprolol with heart rate reduction, and atenolol and metoprolol with weight gain and hyperglycemia. Physicians preferred prescribing β-blockers with lower risk of incident diabetes. Clinical practice guidelines influenced physician prescribing more than formularies or performance metrics. This survey captures physicians' perceptions/use of various β-blockers and clinically relevant knowledge gaps.

SUBMITTER: Egan B 

PROVIDER: S-EPMC6220865 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC1865458 | biostudies-literature
| S-EPMC7950072 | biostudies-literature
| S-EPMC1471831 | biostudies-other
| S-EPMC6374168 | biostudies-literature
| S-EPMC2533291 | biostudies-literature
| S-EPMC4385975 | biostudies-literature
| S-EPMC6835990 | biostudies-literature
| S-EPMC2464396 | biostudies-literature
| S-EPMC3565892 | biostudies-literature
| S-EPMC8440726 | biostudies-literature